Trex hires product marketing VP for Lorad
Trex Medical has named Christopher Lynch to the new position of associate vice president of product marketing for Lorad Breast Imaging products. As part of his responsibilities, Lynch will develop and implement marketing strategies for Lorad’s
Trex Medical has named Christopher Lynch to the new position of associate vice president of product marketing for Lorad Breast Imaging products. As part of his responsibilities, Lynch will develop and implement marketing strategies for Lorads existing and future products, including its line of mammography systems: M-IV, Elite, and Contour, as well as its MultiCare prone breast biopsy and StereoLoc II upright stereotactic systems. Lynch brings more than 10 years experience to the post, and previously has held various marketing, manufacturing, and R&D positions at Agfa.
ASCO: Study Reveals Significant Racial/Ethnic Disparities with PSMA PET Use for Patients with mPCa
May 30th 2025Latinx patients with metastatic prostate cancer were 63 percent less likely than non-Hispanic White patients to have PSMA PET scans, according to a study of 550 patients presented at the American Society of Clinical Oncology (ASCO) conference.
Lunit Unveils Enhanced AI-Powered CXR Software Update
May 28th 2025The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.
New MRI Study Questions Use of Corticosteroid Injections for Knee OA
May 27th 2025Two years after intraarticular knee injections for knee osteoarthritis (OA), study participants who had corticosteroid knee injections had greater OA progression than control patients while the use of hyaluronic acid injections was associated with less OA progression.
